Mike Huckman submits: I'm not gonna blog about the new Vytorin studies as there's been a plethora of coverage all over, including on CNBC. The only thing I wanted to mention was that while I was on the New England Journal of Medicine Web site on Monday preparing...
Mike Huckman submits: Eli Lilly LLY has been running direct-to-doctor ads over the past few months telling physicians that Effient, the company's new bloodthinner, is "Coming Soon." Well, it may have jumped the gun. The Food and Drug Administration, which had put Effient on a fast-track toward potential...
Mike Huckman submits: Last week I blogged about Eli Lilly's LLY "Coming Soon" banner ad I spotted in the online edition of The New England Journal of Medicine. It's designed to generate buzz about the company's crucial new bloodthinner that could win Food and Drug Administration approval this month....
Considerable Opportunity Remains for an Antiplatelet Therapy that, Combined with Aspirin, Causes Less Bleeding than the Combination of Plavix/Iscover and Aspirin, According to a New Report from Decision Resources
Today came the news that Eli Lilly is one of the mystery suitors in the ImClone deal that Bristol-Myers Squibb was just booted from. If CEO John Lechleiter were to scoop up ImClone -- thus bolting on the cancer specialist's pipeline to replace the absence of its...
Powerful, Dell is built to fit your business needs Customized systems, experts trained in small business, 24/7/365 support, and powerful, reliable technology. Dell, big results for small business.
With AT&T Tech Support 360, you'll have certified, U.S. based technicians on call 24/7 to help keep your computers, connections, software and peripherals up to speed for just 82¢ a day.
